These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7939912)

  • 1. Safe administration of iron dextran to a patient who reacted to the test dose.
    Monaghan MS; Glasco G; St John G; Bradsher RW; Olsen KM
    South Med J; 1994 Oct; 87(10):1010-2. PubMed ID: 7939912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of the total dose intravenous infusion of iron dextran.
    Auerbach M; Witt D; Toler W; Fierstein M; Lerner RG; Ballard H
    J Lab Clin Med; 1988 May; 111(5):566-70. PubMed ID: 3361236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful administration of iron dextran in a patient who experienced a life threatening reaction to intravenous iron dextran.
    Hickman MA; Bernstein IL; Palascak JE
    Ann Allergy Asthma Immunol; 2000 Feb; 84(2):262-3. PubMed ID: 10719785
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal anaphylaxis after intravenous iron dextran.
    Zipf RE
    J Forensic Sci; 1975 Apr; 20(2):326-33. PubMed ID: 1123602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How safe is it to give parenteral iron to a patient with rheumatoid arthritis (RA) and iron deficiency anaemia?
    Merry P; Kidd B; Blake DR
    Br J Rheumatol; 1989 Feb; 28(1):22. PubMed ID: 2917225
    [No Abstract]   [Full Text] [Related]  

  • 10. Parenteral iron dextran therapy.
    Kumpf VJ; Holland EG
    DICP; 1990 Feb; 24(2):162-6. PubMed ID: 2106757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.
    Koutroubakis IE; Oustamanolakis P; Karakoidas C; Mantzaris GJ; Kouroumalis EA
    Dig Dis Sci; 2010 Aug; 55(8):2327-31. PubMed ID: 19834803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral iron therapy options.
    Silverstein SB; Rodgers GM
    Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral iron therapy: a single institution's experience over a 5-year period.
    Laman CA; Silverstein SB; Rodgers GM
    J Natl Compr Canc Netw; 2005 Nov; 3(6):791-5. PubMed ID: 16316614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening Reaction to Iron Dextran: Protocol for Induction of Tolerance.
    Cardona R; Sánchez J; Ramírez R
    J Investig Allergol Clin Immunol; 2016; 26(1):48-9. PubMed ID: 27012016
    [No Abstract]   [Full Text] [Related]  

  • 16. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease.
    Mamula P; Piccoli DA; Peck SN; Markowitz JE; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):286-90. PubMed ID: 11964953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of parenteral iron dextran therapy.
    Burns DL; Pomposelli JJ
    Kidney Int Suppl; 1999 Mar; 69():S119-24. PubMed ID: 10084295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral iron use in the management of anemia in end-stage renal disease patients.
    Bailie GR; Johnson CA; Mason NA
    Am J Kidney Dis; 2000 Jan; 35(1):1-12. PubMed ID: 10620537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of intravenous iron dextran in hemodialysis patients.
    Fishbane S; Ungureanu VD; Maesaka JK; Kaupke CJ; Lim V; Wish J
    Am J Kidney Dis; 1996 Oct; 28(4):529-34. PubMed ID: 8840942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is low-molecular weight iron dextran really the most risky iron?--Unconvincing data from an unconvincing study.
    DeLoughery TG; Auerbach M
    Am J Hematol; 2016 May; 91(5):451-2. PubMed ID: 26873795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.